Observational studyBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2020
Post-Marketing Pooled Safety Analysis for CT-P13 Treatment of Patients with Immune-Mediated Inflammatory Diseases in Observational Cohort Studies.
Sang Joon Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it